This article explains how absorption, scattering, wavelength, tissue composition, and device geometry determine optical dose in red light therapy. It distinguishes surface exposure from deep-tissue dose, reviews proposed PBM photoacceptors, and clarifies what optical tests, safety standards, quality systems, and FDA status can—and cannot—demonstrate.